beta

ADXS

Advaxis, Inc.

Adxs

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Market Cap: 14.9 Million

Primary Exchange: NASDAQ

Website: http://www.advaxis.com

Shares Outstanding: 24.7 Million

Float: 24.4 Million

Dividend: (%)

Beta: 1.61692854206866

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1149 trading days

From: 2015-06-01 To: 2019-12-04

Lowest Point:

Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-06-11 10:53:04:000

Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...

Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-06-11 10:53:04:000

Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...

Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2019-06-11 10:53:04:000

Advaxis, Inc. (ADXS) Q2 2019 Earnings Conference Call June 11, 2019 11:00 A.M. ET Company Participants Yvonne Briggs - Vice President, LHA Kenneth Berlin - President and Chief Executive Officer Andres Gutierrez - Executive Vice President and Chief Medical Officer Molly Henderso… read more...

Caseys General Stores among after hour gainers

via: SeekingAlpha at 2019-06-10 13:38:05:000

Gainers: NBY +20.3% . CASY +9.4% . KEG +3.5% . CHAP +3.2% . CXW +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more … read more...

Advaxis  EPS misses by $0.02, beats on revenue

via: SeekingAlpha at 2019-06-10 12:08:10:000

Advaxis (NASDAQ: ADXS ): Q2 GAAP EPS of -$1.59 misses by $0.02 . More news on: Advaxis, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Advaxis Reports Second Quarter Fiscal 2019 Financial Results and Provides Pipeline Update

via: Business Wire at 2019-06-10 12:05:00:000

Conference call to be held June 11 at 11:00 a.m. ET Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced an update on its clinical pipeline and financial results … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud